We share our founders' passion for transformative technologies
Our roots are in
We invest across
across life science, software and
We provide follow-on funding up to
In a nutshell
people work in
Gateway to an
in our portfolio
We have strong ties to
at the Institute of Science and
Our companies have raised
> € 140mn
in grants and equity funding.
Our starting point is a strong founding team with grit
We help you transition from a science project to a commercial venture.
We focus on your needs.
We're here for you every step of the way, from negotiating university agreements to navigating corporate partnerships.
We let you focus on your needs.
Minimize distractions and let our expertise in finance, IP, grant acquisition, and HR help your business thrive.
We are transparent. Here is our term sheet.
We are scientists & investors. And a whole lot more.
Bringing the two forces together is our mission. Our team’s unparalleled expertise in both science and business and our broad network turns ideas into reality.
Company in the Spotlight
By means of synthetic biology and genetic code expansion Valanx has developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. Based on this platform Valanx is developing a number of cutting-edge biologics towards potential treatments for various indications.